Why is Sandu Pharma. falling/rising?

As of 19-Sep, Sandu Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 47.21, reflecting a decrease of 0.73 or 1.52%. The stock has underperformed its sector by 1.06% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 3.55%. Additionally, Sandu Pharmaceuticals is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a high dividend yield of 3.34%, the stock's performance over the past year has been poor, with a return of -24.34%, and it has consistently underperformed against benchmarks over the last three years. The company's weak long-term fundamentals, highlighted by a low return on equity of 3.7% and a poor EBIT to interest ratio, further contribute to the stock's negative sentiment.
In the broader market context, Sandu Pharmaceuticals has shown a short-term return of +0.96% over the past week, which is slightly better than the Sensex's return of +0.88%. However, the stock's performance over the longer term is concerning, with a year-to-date decline of -17.55% compared to the Sensex's gain of +5.74%. This underperformance, coupled with a significant drop in investor participation, as evidenced by a 58.31% decrease in delivery volume, suggests a lack of confidence among investors. Overall, the combination of weak fundamentals, declining investor interest, and consistent underperformance against benchmarks is driving the stock's downward movement.